Digital PCR (dPCR) Market - Overview, Size, Share by 2031

Digital PCR (dPCR) Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology [Droplet Digital PCR (ddPCR) and BEAMing Digital PCR], Component (Instruments, Reagents and Consumables, and Software and Services), Application (Clinical, Research, and Forensic), End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organization), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

  • Report Code : TIPRE00039160
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Digital PCR (dPCR) Market - Overview, Size, Share by 2031

Buy Now

The Digital PCR (dPCR) market size is projected to reach US$ 15.63 billion by 2031 from US$ 6.97 billion in 2023; the market is estimated to record a CAGR of 9.9% during 2023–2031.

dPCR is a breakthrough technology that offers ultrasensitive and absolute nucleic acid quantification. It is one of the most accurate, precise, and sensitive techniques for the detection of specific nucleic acid sequences. It has become a crucial and reliable tool for molecular analysis. Increasing incidence of genetic and infectious diseases which can bi diagnosed and treated using dPCR techniques supports the growth of the Digital PCR (dPCR) market. The Digital PCR (dPCR) market trends include technological advancements that aid high-precision and absolute quantification of target DNA molecules, thus enabling a wide range of applications in diagnosis and research.

Growth Drivers:

Gene synthesis is the most accepted tool in the field of recombinant DNA technology. In gene synthesis, recombinant protein expression and dPCR technology are used for amplification as well as quantification purposes. In 2021, Camena Bioscience, a synthetic biology startup that supplies genes to the biotechnology and pharmaceutical industries, completed a US$ 10 million Series A funding round headed by Mercia. With the additional funds, the company plans to expand its operations and power its efforts of developing gSynth, its ground-breaking DNA synthesis platform. The technology platform and other related resources help the company to accelerate the development of gene synthesis.

In 2020, EVONETIX LTD, a synthetic biology startup creating a desktop platform for high-fidelity, rapid, and scalable gene synthesis, announced the completion of its Series B financing round. The company, led by Foresite Capital (a new investor), raised US$ 30 million (£23 million) in this round. Thus, rising investments by companies fuel the gene synthesis market growth, thereby contributing to the Digital PCR (dPCR) market growth.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Digital PCR (dPCR) Market: Strategic Insights

digital-pcr-dpcr-market
Analyst Image

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Report Segmentation and Scope:

The Digital PCR (dPCR) market analysis has been carried out by considering the following segments: technology, component, application, end user, and geography. Based on technology, the market is segmented into droplet digital PCR (ddPCR) and BEAMing digital PCR. In terms of component, the market is classified into instruments, reagents and consumables, and software and services. Based on application, the market is categorized into clinical, research, and forensic. The geographic scope of the Digital PCR (dPCR) market report covers North America (US, Canada, and Mexico), Europe (France, Germany, UK, Spain, Italy, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, South Africa, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Segmental Analysis:

The Digital PCR (dPCR) market, by product, is categorized into droplet digital PCR (ddPCR) and BEAMing digital PCR. The ddPCR segment held a significant market share in 2023. It is anticipated to record the highest CAGR in the market during 2023–2031.

Based on component, the market is categorized into instruments, reagents and consumables, and software and services indications. The reagents and consumables segment held a significant market share in 2023, and it is estimated to register the highest CAGR during 2023–2031.

Based on application, the market is segmented into clinical, research, and forensic. The clinical segment held a significant Digital PCR (dPCR) market share in 2023; it is expected to register the highest CAGR during 2023–2031.

Based on end user, the market is segmented into hospitals and diagnostic centers, pharmaceutical and biotech companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held a significant Digital PCR (dPCR) market share in 2023; it is expected to register the highest CAGR during 2023–2031.

Regional Analysis:

In terms of geography, the Digital PCR (dPCR) market is segmented into North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2023, North America captured a significant share of the market. In 2023, the US dominated the market in this region. The Digital PCR (dPCR) market growth in North America is attributed to scientific conferences, workshops, and events conducted in the US and Canada, which help participants from different parts of the world exchange trends and the latest research outcomes based on PCR. For instance, the Global Information Incorporation’s Global Engage conducted a two-day summit featuring the contribution of worldwide scientists on dPCR strategies and development as well as discuss case studies that involve the contribution of dPCR in healthcare. The active involvement of the country is also one of the driving factors leading to the growth of the region in the global Digital PCR (dPCR) market in the region.

Industry Developments and Future Opportunities:

The Digital PCR (dPCR) market report includes company positioning and concentration to evaluate the performance of competitors in the market. As per company press releases, a few initiatives taken by key players operating in the market are mentioned below:

  • In July 2023, Bio-Rad Laboratories, Inc. launched its first ultrasensitive multiplexed dPCR assay—the ddPLEX ESR1 Mutation Detection Kit. With the launch of this product, the company plans to extend the availability of its ddPCR offering for the oncology market, where highly sensitive and multiplexed mutation detection assays aid translational research, therapy selection, and disease monitoring.
  • In June 2021, Bio-Rad Laboratories Inc. introduced the “Prevalence ddPCR SARS-CoV-2 Wastewater Quantification Kit,” a sensitive, cost-effective, and accurate instrument for detecting SARS-CoV-2 in the community wastewater.
  • The Centers for Disease Control and Prevention (CDC) recommends ddPCR techniques for wastewater testing, and the Environmental Protection Agency (EPA) has published the technology as a reliable way to quantify viruses in wastewater.

Digital PCR (dPCR) Market Report Scope

Competitive Landscape and Key Companies:

The Digital PCR (dPCR) market forecast can help stakeholders plan their growth strategies. Thermo Fisher Scientific, Inc.; F. Hoffmann-la Roche Ltd.; QIAGEN; Akara bio, Inc.; Agilent Technologies, Inc.; Biomerieux SA; Abbott Laboratories; Merck KgaA; Promega Corporation; and BD are among the prominent players profiled in the market. These companies focus on introducing new high-tech products, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are dPCR?

dPCR is a new technique utilized for DNA amplification and quantification that uses molecular counting protocol. dPCR is usually used to distinguish the expression of alleles, track viral infection to individual bacterial cells, quantify cancer genes, and detect fetal DNA in circulating blood.

What are the growth estimates for the Digital PCR (dPCR) market till 2031?

The Digital PCR (dPCR) market is expected to be valued at US$ 15.63 billion by 2031.

Which segment is dominating the Digital PCR (dPCR) market?

The global Digital PCR (dPCR) market is segmented based on technology, component, application, and end user. The Digital PCR (dPCR) market, by component, is categorized into instruments, reagents and consumables, and software and services. The reagents and consumables segment held a significant market share in 2023 and is anticipated to record the highest CAGR in the market during 2023–2031.

What is the driving and restraining factors for the Digital PCR (dPCR) market?

The factors driving the growth of the Digital PCR (dPCR) market include the rising incidence of infectious diseases and technological advancements in PCR technologies. However, the high costs of PCR systems, hampers the growth of the Digital PCR (dPCR) market.

What was the estimated Digital PCR (dPCR) market size in 2023?

The Digital PCR (dPCR) market was valued at US$ 6.97 billion in 2023.

Who are the major players in the Digital PCR (dPCR) market?

The Digital PCR (dPCR) market majorly consists of the players, including Thermo Fisher Scientific, Inc.; F. Hoffmann-la Roche Ltd.; QIAGEN; Akara bio, Inc.; Agilent Technologies, Inc.; Biomerieux SA; Abbott Laboratories; Merck KgaA; Promega Corporation; and BD.

1. Introduction

1.1 Scope of the Study

1.2 Market Definition, Assumptions and Limitations

1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights

2.2 Market Attractiveness Analysis

3. Research Methodology

4. Digital PCR (dPCR) market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Digital PCR (dPCR) market - Key Market Dynamics

5.1 Key Market Drivers

5.2 Key Market Restraints

5.3 Key Market Opportunities

5.4 Future Trends

5.5 Impact Analysis of Drivers and Restraints

6. Digital PCR (dPCR) market - Global Market Analysis

6.1 dPCR - Global Market Overview

6.2 dPCR - Global Market and Forecast to 2031

7. Digital PCR (dPCR) market – Revenue Analysis (USD Million) – By Technology, 2021-2031

7.1 Overview

7.2 Droplet Digital PCR (ddPCR)

7.3 BEAMing Digital PCR

8. Digital PCR (dPCR) market – Revenue Analysis (USD Million) – By Component, 2021-2031

8.1 Overview

8.2 Instruments

8.3 Reagents and Consumables

8.4 Software and Services

9. Digital PCR (dPCR) market – Revenue Analysis (USD Million) – By Application, 2021-2031

9.1 Overview

9.2 Clinical

9.3 Research

9.4 Forensics

10. Digital PCR (dPCR) market – Revenue Analysis (USD Million) – By End User, 2021-2031

10.1 Overview

10.2 Hospitals and Diagnostic Centers

10.3 Pharmaceutical and Biotech Companies

10.4 Research Laboratories and Academic Institutes

10.5 Clinical Research Organization

10.6 Forensic Laboratories

11. Digital PCR (dPCR) market - Revenue Analysis (USD Million), 2021-2031 – Geographical Analysis

11.1 North America

11.1.1 North America Digital PCR (dPCR) market Overview

11.1.2 North America Digital PCR (dPCR) market Revenue and Forecasts to 2031

11.1.3 North America Digital PCR (dPCR) market Revenue and Forecasts and Analysis - By Technology

11.1.4 North America Digital PCR (dPCR) market Revenue and Forecasts and Analysis - By Component

11.1.5 North America Digital PCR (dPCR) market Revenue and Forecasts and Analysis - By Application

11.1.6 North America Digital PCR (dPCR) market Revenue and Forecasts and Analysis - By End User

11.1.7 North America Digital PCR (dPCR) market Revenue and Forecasts and Analysis - By Countries

11.1.7.1 United States Digital PCR (dPCR) market

11.1.7.1.1 United States Digital PCR (dPCR) market, by Technology

11.1.7.1.2 United States Digital PCR (dPCR) market, by Component

11.1.7.1.3 United States Digital PCR (dPCR) market, by Application

11.1.7.1.4 United States Digital PCR (dPCR) market, by End User

11.1.7.2 Canada Digital PCR (dPCR) market

11.1.7.2.1 Canada Digital PCR (dPCR) market, by Technology

11.1.7.2.2 Canada Digital PCR (dPCR) market, by Component

11.1.7.2.3 Canada Digital PCR (dPCR) market, by Application

11.1.7.2.4 Canada Digital PCR (dPCR) market, by End User

11.1.7.3 Mexico Digital PCR (dPCR) market

11.1.7.3.1 Mexico Digital PCR (dPCR) market, by Technology

11.1.7.3.2 Mexico Digital PCR (dPCR) market, by Component

11.1.7.3.3 Mexico Digital PCR (dPCR) market, by Application

11.1.7.3.4 Mexico Digital PCR (dPCR) market, by End User

Note - Similar analysis would be provided for below mentioned regions/countries

11.2 Europe

11.2.1 Germany

11.2.2 France

11.2.3 Italy

11.2.4 Spain

11.2.5 United Kingdom

11.2.6 Rest of Europe

11.3 Asia-Pacific

11.3.1 Australia

11.3.2 China

11.3.3 India

11.3.4 Japan

11.3.5 South Korea

11.3.6 Rest of Asia-Pacific

11.4 Middle East and Africa

11.4.1 South Africa

11.4.2 Saudi Arabia

11.4.3 U.A.E

11.4.4 Rest of Middle East and Africa

11.5 South and Central America

11.5.1 Brazil

11.5.2 Argentina

11.5.3 Rest of South and Central America

12. Industry Landscape

12.1 Mergers and Acquisitions

12.2 Agreements, Collaborations, Joint Ventures

12.3 New Product Launches

12.4 Expansions and Other Strategic Developments

13. Competitive Landscape

13.1 Heat Map Analysis by Key Players

13.2 Company Positioning and Concentration

14. Digital PCR (dPCR) market - Key Company Profiles

14.1 Thermo Fisher Scientific, Inc.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

Note - Similar information would be provided for below list of companies

14.2 F. Hoffman-La Roche

14.3 QIAGEN NV

14.4 Akara Bio, Inc.

14.5 Agilent Technologies

14.6 bioMérieux SA

14.7 Abbott Laboratories

14.8 Merck

14.9 Promega Corporation

14.10 BD

15. Appendix

15.1 Glossary

15.2 About The Insight Partners

15.3 Market Intelligence Cloud

The List of Companies - Digital PCR (dPCR) Market

  1. Thermo Fisher Scientific, Inc.
  2. F. Hoffmann-la Roche Ltd
  3. QIAGEN
  4. Akara bio, Inc.
  5. Agilent Technologies, Inc.
  6. Biomerieux SA
  7. Abbott Laboratories
  8. Merck KgaA
  9. Promega Corporation
  10. BD.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..